云南白药公司股利优化与建议.pdfVIP

云南白药公司股利分配政策优化与建议 摘 要 股利分配政策是企业财务管理的核心内容，适应企业发展现状且科学合理的 股利政策不仅能为企业创新战略发展提供充足的空间、树立企业良好形象，还能 让投资者感受到企业发展的可持续性。云南白药作为我国医药上市公司的一个典 型代表，其股利政策研究对提升企业价值具有重要意义。本文以云南白药集团为 主要研究对象,通过文献分析、比较研究和案例分析方法探讨云南白药集团的股 利分配情况，为完善股利政策和公司治理提供理论依据。通过与其他同行业企业 的对比研究发现，云南白药集团的分红一直低于同行业其他企业，股利政策波动 较大，缺乏稳定性和连续性，市场不满情绪累积严重，主要表现为股利分配方式 单一，现金股利支付水平偏低，股利分配政策稳定性不足等特点。针对云南白药 股息分配政策目前存在的问题,本文为云南白药未来的股息分配政策提供切实可 行的建议：提高企业现金股利支付水平，加强对公司股利政策稳定性的规范，引 导云南白药优化股利分配政策并有效执行,改善企业内部管理结构，提升企业价 值 关键词：股利分配政策；企业治理；医药上市公司；云南白药 1 Optimization and Suggestions on Dividend Distribution Policy of Yunnan Baiyao Group Co., Ltd. Abstract Dividend distribution policy is the core content of corporate financial management. A scientific and reasonable dividend policy that adapts to the status quo of corporate development can not only provide sufficient space for the development of innovative strategies, establish a good corporate image, but also allow investors to feel that the enterprise is a promising place for development. Yunnan Baiyao Group Co., Ltd.(Hereinafter referred to as Yunnan Baiyao), as a typical representative of Chinas listed pharmaceutical companies, has great research value in formulating its dividend policy. This article takes Yunnan Baiyao as the main research object, and discusses the dividend distribution of Yunnan Baiyao through literature analysis, comparative research and case analysis methods, and provides theoretical basis for improving dividend policy and corporate governance. Through a comparative study with other companies in the same industry, it is found that the dividends of Yunnan Baiyao have always been lower than those of other companies in the same industry. The dividend policy is relatively chaotic,